Maya Kansara

2.9k total citations · 2 hit papers
31 papers, 2.2k citations indexed

About

Maya Kansara is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Maya Kansara has authored 31 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Maya Kansara's work include Cancer Genomics and Diagnostics (9 papers), Cancer-related Molecular Pathways (7 papers) and Epigenetics and DNA Methylation (4 papers). Maya Kansara is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Cancer-related Molecular Pathways (7 papers) and Epigenetics and DNA Methylation (4 papers). Maya Kansara collaborates with scholars based in Australia, United States and New Zealand. Maya Kansara's co-authors include David M. Thomas, Mark J. Smyth, Michele W.L. Teng, Michael V. Berridge, John Slavin, Paul J. Simmons, Peter Choong, Melanie Trivett, Nuzhat Ahmed and Carleen Cullinane and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Maya Kansara

28 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Translational biology of osteosarcoma

2014 978 citations Maya Kansara, Michele W.L. Teng et al. Nature reviews. Cancer profile →
Topological barrier to Cas12a activation by circular DNA nanostructures facilitates autocatalysis and transforms DNA/RNA sensing

2024 81 citations Fei Deng, Yi Li et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maya Kansara Australia	14	1.3k	631	580	574	229	31	2.2k
Jacson Shen United States	28	981 0.7×	523 0.8×	617 1.1×	689 1.2×	205 0.9×	52	2.0k
Rui Yang China	22	735 0.6×	413 0.7×	379 0.7×	406 0.7×	173 0.8×	99	1.6k
Pierrick G.J. Fournier United States	26	1.1k 0.8×	415 0.7×	498 0.9×	1.7k 3.0×	180 0.8×	37	2.8k
Michela Pasello Italy	24	869 0.7×	344 0.5×	435 0.8×	475 0.8×	145 0.6×	45	1.8k
Nicholas Willumsen Denmark	26	609 0.5×	455 0.7×	330 0.6×	811 1.4×	366 1.6×	82	2.0k
Truong D. Dang United States	16	886 0.7×	380 0.6×	714 1.2×	511 0.9×	187 0.8×	19	1.8k
Marc Baud’huin France	26	1.2k 0.9×	314 0.5×	200 0.3×	706 1.2×	335 1.5×	50	2.1k
Noritaka Ohga Japan	30	1.9k 1.4×	949 1.5×	211 0.4×	745 1.3×	318 1.4×	84	2.8k
Tilly Aalders Netherlands	17	932 0.7×	563 0.9×	969 1.7×	405 0.7×	100 0.4×	29	1.9k
Ying Ma China	20	741 0.6×	310 0.5×	243 0.4×	620 1.1×	480 2.1×	81	1.7k

Countries citing papers authored by Maya Kansara

Since Specialization

Citations

This map shows the geographic impact of Maya Kansara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maya Kansara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maya Kansara more than expected).

Fields of papers citing papers by Maya Kansara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maya Kansara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maya Kansara. The network helps show where Maya Kansara may publish in the future.

Co-authorship network of co-authors of Maya Kansara

This figure shows the co-authorship network connecting the top 25 collaborators of Maya Kansara. A scholar is included among the top collaborators of Maya Kansara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maya Kansara. Maya Kansara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Frank, John P. Grady, Christine E. Napier, et al.. (2024). Impact of artificial intelligence (AI) decision support on clinical trial participation: A before-after implementation study on a nationwide molecular tumor board.. Journal of Clinical Oncology. 42(16_suppl). 1557–1557. 1 indexed citations

Deng, Fei, Yi Li, Biyao Yang, et al.. (2024). Topological barrier to Cas12a activation by circular DNA nanostructures facilitates autocatalysis and transforms DNA/RNA sensing. Nature Communications. 15(1). 1818–1818. 81 indexed citations breakdown →

Thavaneswaran, Subotheni, Hao‐Wen Sim, John P. Grady, et al.. (2024). A phase II trial of larotrectinib in tumors with NTRK fusions or extremes of NTRK mRNA overexpression identified by comprehensive genomic profiling. The Oncologist. 30(8).

Thavaneswaran, Subotheni, Maya Kansara, Frank Cheau‐Feng Lin, et al.. (2023). A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterations. British Journal of Cancer. 129(3). 475–485. 7 indexed citations

Vaghjiani, Vijesh, Catherine R. Cochrane, W. Samantha N. Jayasekara, et al.. (2023). Ligand-dependent hedgehog signaling maintains an undifferentiated, malignant osteosarcoma phenotype. Oncogene. 42(47). 3529–3541. 2 indexed citations

Kansara, Maya, Neeru Bhardwaj, Subotheni Thavaneswaran, et al.. (2022). Early circulating tumor DNA dynamics as a pan‐tumor biomarker for long‐term clinical outcome in patients treated with durvalumab and tremelimumab. Molecular Oncology. 17(2). 298–311. 6 indexed citations

Lin, Frank, Subotheni Thavaneswaran, John P. Grady, et al.. (2021). Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncology. npj Precision Oncology. 5(1). 58–58. 6 indexed citations

Kansara, Maya, Puiyi Pang, Aurélie Dutour, et al.. (2019). Infiltrating Myeloid Cells Drive Osteosarcoma Progression via GRM4 Regulation of IL23. Cancer Discovery. 9(11). 1511–1519. 35 indexed citations

Thavaneswaran, Subotheni, Mandy L. Ballinger, John P. Grady, et al.. (2019). The Cancer Molecular Screening and Therapeutics Program (MoST): Actionable mutation frequencies in a population with rare and less common cancers.. Journal of Clinical Oncology. 37(15_suppl). 3136–3136. 1 indexed citations

10.

Kansara, Maya & David M. Thomas. (2014). RB1-mediated cell-autonomous and host-dependent oncosuppressor mechanisms in radiation-induced osteosarcoma. OncoImmunology. 3(2). e27569–e27569. 5 indexed citations

11.

Kansara, Maya, Michele W.L. Teng, Mark J. Smyth, & David M. Thomas. (2014). Translational biology of osteosarcoma. Nature reviews. Cancer. 14(11). 722–735. 978 indexed citations breakdown →

12.

Etemadmoghadam, Dariush, George Au‐Yeung, Meaghan Wall, et al.. (2013). Resistance to CDK2 Inhibitors Is Associated with Selection of Polyploid Cells in CCNE1 -Amplified Ovarian Cancer. Clinical Cancer Research. 19(21). 5960–5971. 90 indexed citations

13.

Paget, Christophe, Helene Duret, Shin Foong Ngiow, et al.. (2012). Studying the role of the immune system on the antitumor activity of a Hedgehog inhibitor against murine osteosarcoma. OncoImmunology. 1(8). 1313–1322. 8 indexed citations

14.

Etemadmoghadam, Dariush, Joshy George, Prue A. Cowin, et al.. (2010). Amplicon-Dependent CCNE1 Expression Is Critical for Clonogenic Survival after Cisplatin Treatment and Is Correlated with 20q11 Gain in Ovarian Cancer. PLoS ONE. 5(11). e15498–e15498. 74 indexed citations

15.

Kansara, Maya, Michael Tsang, Laurent Kodjabachian, et al.. (2009). Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice. Journal of Clinical Investigation. 119(4). 837–851. 227 indexed citations

16.

Kansara, Maya & David M. Thomas. (2007). Molecular Pathogenesis of Osteosarcoma. DNA and Cell Biology. 26(1). 1–18. 209 indexed citations

17.

Thomas, David M. & Maya Kansara. (2006). Epigenetic modifications in osteogenic differentiation and transformation. Journal of Cellular Biochemistry. 98(4). 757–769. 49 indexed citations

18.

Morgan, Teresa, Gerald J. Atkins, Melanie Trivett, et al.. (2005). Molecular Profiling of Giant Cell Tumor of Bone and the Osteoclastic Localization of Ligand for Receptor Activator of Nuclear Factor κB. American Journal Of Pathology. 167(1). 117–128. 100 indexed citations

19.

Kansara, Maya & Michael V. Berridge. (2003). Hemopoietic cell transformation is associated with failure to downregulate glucose uptake during the G2/M phase of the cell cycle. Experimental Cell Research. 293(2). 321–330. 4 indexed citations

20.

Ahmed, Nuzhat, Maya Kansara, & Michael V. Berridge. (1997). Acute regulation of glucose transport in a monocyte–macrophage cell line: Glut-3 affinity for glucose is enhanced during the respiratory burst. Biochemical Journal. 327(2). 369–375. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact